This inventor holds 2 USPTO granted patents. Top assignee: Ares Trading S.a.. Active years: 2011-2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Ville-la-Grand, FR (2011)
- Brussels, BE (2015)
Company Filing History:
Years Active: 2011-2015
Title: Alain Bernard: Innovator in Biotechnology
Introduction
Alain Bernard is a notable inventor based in Brussels, Belgium. He has made significant contributions to the field of biotechnology, particularly in the development of processes related to interferon beta and the recycling of solid supports for cell cultivation. With a total of 2 patents, his work has implications for both medical and industrial applications.
Latest Patents
Bernard's latest patents include a process for the preparation of glycosylated interferon beta. This invention focuses on producing interferon beta with a unique glycosylation pattern, which is crucial for its therapeutic efficacy. Another significant patent is for a method of recycling solid supports used for the cultivation of anchorage-dependent cells. This method enhances protein productivity levels by allowing the reuse of solid supports, such as microcarriers and Fibra-Cel® disks, through a series of rinsing steps.
Career Highlights
Alain Bernard is associated with Ares Trading S.a., where he applies his expertise in biotechnology to drive innovation. His work has been instrumental in advancing methods that improve the efficiency of protein production, which is vital for various biopharmaceutical applications.
Collaborations
Throughout his career, Bernard has collaborated with notable professionals in the field, including Paul Ducommun and Frederic Papp. These collaborations have fostered a productive environment for innovation and research.
Conclusion
Alain Bernard's contributions to biotechnology through his patents and collaborations highlight his role as a key innovator in the industry. His work continues to influence advancements in medical and industrial biotechnology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile